Use of quinupristin/dalfopristin in a critical patient with a methicillin-resistant Staphilococcus aureus infection;Uso di quinupristin/dalfopristin in un paziente critico con un'infezione da Staphilococcus aureus meticillino-resistente

Minerva Anestesiologica

Volumn 70, Issue 10, 2004, Pages 747-751

  De Robertis, E ^a,b   Viscidi, D ^a   Servillo, G ^a   Pezza, M ^a   Piazza, O ^a   Giuliano, C A ^a   Tufano, R ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Istituto di Anestesia e Rianimazione   (Italy)

Author keywords

Drug resistance, bacterial infections; Methicillin resistance; Quinupristin dalfopristin; Staphylococcus aureus

Indexed keywords

COLISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; MEROPENEM; METICILLIN; POLYPEPTIDE ANTIBIOTIC AGENT; STREPTOGRAMIN; TEICOPLANIN; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CULTURE; BRONCHUS BIOPSY; CASE REPORT; CLINICAL FEATURE; CRITICAL ILLNESS; DISEASE ASSOCIATION; EXTUBATION; FEVER; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; IN VITRO STUDY; INSTRUMENT STERILIZATION; LEUKOCYTOSIS; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PHLEBITIS; SEPSIS; STAPHYLOCOCCUS INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; HUMANS; MALE; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; THORACIC INJURIES; TOMOGRAPHY, X-RAY COMPUTED; VIRGINIAMYCIN; WOUNDS, STAB;

EID: 9744240903     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Malacarne P, Stella A, Giudici D, Bertolini G. Infection surveillance in intensive care units. Preliminary results of a multicenter GiViTI study in 71 Italian ICUs. Minerva Anestesiol 2004;70:321-8.
2. Manzella JP. Quinupristin-dalfopristin: a new antibiotic for severe gram-positive infections. Am Fam Physician 2001;64:1863-6.
3. Rehm SJ, Graham DR, Srinath L, Prokocimer P, Richard MP, Talbot GH. Successful administration of quinupristin/dalfopristin in the outpatient setting. J Antimicrob Chemother 2001;47:639-45.
4. Drew RH, Perfect JR, Srinath L, Kurkimilis E, Dowzicky M, Talbot GH. Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. J Antimicrob Chemother 2000;46:775-84.
5. Corona A, Raimondi F. Infection control and prevention in Intensive Care: environmental aspects. Min Anestesiol 2003;69:308-14.
6. Wood MJ. The comparative efficacy and safety of teicoplanin and vancomycin. J Antimicrob Chemother 1996;37:209-22.
7. Etienne J. Epidemiological context: microbiological value of Synercid. Presse Med 2001;30(25 Pt 2):6-9.